On June 10, Bristol-Myers Squibb announced a voluntary recall of one lot (#HN0063) of Eliquis 5 mg tablets. This lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in ...

Bristol-Myers Squibb Company (NYSE: BMY) is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the U.S. to wholesalers and ...

Bristol-Myers Squibb Company has announced that the company is voluntarily recalling one lot of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the US to wholesalers ...

The company is voluntarily recalling one lot of Eliquis after a patient discovered that a bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets. Bristol-Myers Squibb (BMS) is ...

MEMPHIS, Tenn. — Bristol-Myers Squibb is recalling bottles of Eliquis after reports of a tablet mix-up. According to the Food and Drug Administration, a bottle was labeled as containing 5 mg doses ...

Bristol-Myers Squibb is recalling a lot of its anticoagulant Eliquis after a customer got a bottle that contained tablets that were half the prescribed dose. The product, however, was manufactured for ...

U.S. FDA Approves ELIQUIS ® (apixaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation ELIQUIS Demonstrated Superior Risk Reductions Versus Warfarin ...